β-caryophyllene And β-caryophyllene Oxide-natural Compounds Of Anticancer And Analgesic Properties

Pain (Acute) Pain (Chronic Non-Malignant) Pain (Due to Advanced Cancer) Pain (Neuropathies, in general)

Key Findings

Both β-caryophyllene (BCP) and β-caryophyllene oxide (BCPO) possess significant anticancer activities, affecting growth and proliferation of numerous cancer cells. BCP as selective CB2 activator may be taken into account as potential natural analgesic drug. Moreover, due to the fact that chronic pain is often an element of cancer disease, the double activity of BCP, anticancer and analgesic, as well as its beneficial influence on the efficacy of classical chemotherapeutics, is particularly valuable in oncology.

Information and Links


Link: β-caryophyllene And β-caryophyllene Oxide-natural Compounds Of Anticancer And Analgesic Properties

Year: 2016

DOI: 10.1002/cam4.816


Ratings

(How Ratings Work)

Pain (Acute) — 3


Likely probability of the efficacy of cannabis for treatment of Pain (Acute) according to the results found in this study.

Pain (Chronic Non-Malignant) — 3


Likely probability of the efficacy of cannabis for treatment of Pain (Chronic Non-Malignant) according to the results found in this study.

Pain (Due to Advanced Cancer) — 3


Likely probability of the efficacy of cannabis for treatment of Pain (Due to Advanced Cancer) according to the results found in this study.

Pain (Neuropathies, in general) — 3


Likely probability of the efficacy of cannabis for treatment of Pain (Neuropathies, in general) according to the results found in this study.

Drugs Used

β-caryophyllene (BCP) and β-caryophyllene oxide (BCPO)